Effect of cognitive training focusing on organizational strategies in patients with obsessive-compulsive disorder.
The purpose of the present paper was to develop a cognitive training program for patients with obsessive-compulsive disorder (OCD) and evaluate its effectiveness. Nine 60-min sessions focusing on the improvement of organizational strategies were given to 15 patients with OCD over a period of 5 weeks. The control group consisted of 15 age- and sex-matched patients also with OCD. The Rey-Osterrieth Complex Figure Test and Korean-California Verbal Learning Test were administered before and after cognitive training. Clinical symptoms were assessed with the Yale-Brown Obsessive-Compulsive Scale. The memory function in the treatment group improved and their clinical symptoms were alleviated after training, compared to those of the control group. Cognitive training of OCD patients not only improved their memory function, but also alleviated their clinical symptoms. Therefore, cognitive training, focusing on the improvement of organizational strategies, could be an effective treatment modality for patients with OCD.
Park
Hee Soo
HS
Department of Psychiatry, Seoul National University College of Medicine and Neuroscience Institute, SNU-MRC, Korea.
Shin
Yong-Wook
YW
Ha
Tae Hyon
TH
Shin
Min Sup
MS
Kim
Young Youn
YY
Lee
Young Ho
YH
Kwon
Jun Soo
JS
D000203:Activities of Daily Living; D000328:Adult; D014150:Antipsychotic Agents / Q000627:therapeutic use; D003071:Cognition / Q000502:physiology; D015928:Cognitive Behavioral Therapy; D003627:Data Interpretation, Statistical; D005260:Female; D007839:Functional Laterality; D006801:Humans; D008297:Male; D008568:Memory / Q000502:physiology; D009483:Neuropsychological Tests; D009771:Obsessive-Compulsive Disorder / Q000523:psychology* / Q000628:therapy*; D011569:Psychiatric Status Rating Scales; D011597:Psychomotor Performance / Q000502:physiology; D017367:Selective Serotonin Reuptake Inhibitors / Q000627:therapeutic use; D014706:Verbal Learning; D014888:Wechsler Scales
D014150:Antipsychotic Agents; D017367:Selective Serotonin Reuptake Inhibitors